we're seeing you and other companies pulling back from the UK. You know, just last week saw that you were pausing um one of your investments there. So, what's happening in the UK and you know, should that send a message to policy makers here in the US.>> Probably it should. I mean, I think uh the UK has been on a a long slow glide path from a leader in biofarmaceuticals to really a lagard and that's happened over the last 20 years through a number of policy mistakes. Um the most important one is that their ...